The SHIELD I trial of D-PLEX 100 – a new formulation of the well-established antibiotic doxycycline – found that giving the drug wasn't able to improve on regular care in preventing infections ...

The completion of enrollment for the interim analysis of the SHIELD II trial for D-PLEX, PolyPid’s leading pipeline candidate, signals a significant milestone. This phase of the trial assesses ...

Rich Demerara Syrup adds a rich, caramelized sweetness to cocktails and dishes, enhancing the flavors of any recipe. This syrup is essential for anyone who enjoys craft cocktails at home and wants to ...

June 3, 2024 — Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require ...

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined ...

It is expensive because of the low yield from the sap (40 gallons of sap are needed for one gallon of syrup!) but the cheaper imitations labelled ‘maple-flavoured syrup’ made from a mixture of ...

Friends of “Live In The D” share their thoughts on when the holiday season begins Subscribe to the Live in the D newsletter to get all the week’s highlights from the show focused on ...

PolyPid (NASDAQ:PYPD) is a global late clinical-stage biopharma company that specializes in developing, producing, and selling innovative therapies to enhance surgical results. The company’s ...

No significant news for D in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Following its $40 million fundraise at the beginning of this year, streaming media company Plex announced on Wednesday it’s rolling out a new TV show and movie reviews feature, putting its app ...